Trusted Press Release Distribution   Plans | Login    

Briefing Search
Keyword:
Category:

       

    
Author Details
Dr. Rahul Bhargava for blood cancer Treatment
www.indiacancersurgerysite.com
Lisa Resnick
drrahulbhargava@indiacancersurgerysite.com
9371770341
Sohna Road, Near Malibu Town, Sector 75


Bookmark and Share
Dr. Rahul Bhargava Reverses Disabling MS-Like Disease In India With Stem Cell Transplant
Best haemato oncologist in India, said the stem cellular transplant” will quick be regarded as an established treatment in India - and at the same time as that occurs our precedence may be making sure people who ought to gain can surely get it".

BriefingWire.com, 12/24/2021 - Stem cell transplantation appeared to offer more safety than disease-modifying therapy (DMT) towards the development of relapsing-remitting multiple sclerosis (MS), inside the first randomized clinical trial to assess the interventions. Dr. Rahul Bhargava India multiple sclerosis (MS) Specialist defined the unmet need in MS treatment and the capacity for stem cell transplantation as a treatment preference.

Arjun Kumar, a 40 years old man from Mumbai, suffering from multiple sclerosis (MS) for the past seven years, is now symptom-free and advised me: "it feels like a miracle." Multiple sclerosis (MS) is a life-long condition, appeared to reduce life expectancy. MS influences the brain and spinal cord that resulting in crucial disabilities. Arjun, who had been bedridden for a long, is back to his normal ordinary life, was diagnosed with MS an autoimmune illness wherein the body's immune system begins attacking the protective sheet overlaying the nerve cells in the brain and the spinal cord.

By the time Arjun Kumar turned forty, his more than one multiple sclerosis had improved to the point that he would no longer be able to work full time. The worst time was not being able to get off the bed because I had no stability in my body - I struggled to walk or even in the wheelchair. It also affected my cognition - it was like brain fog and that I misinterpret phrases and struggled to maintain up with conversations.

The treatment is an experiment where Arjun was given it as part of the first randomized trial comparing the consequences of patients with what’s known as “relapsing-remitting” MS who obtained the treatment to sufferers who took standard MS medications. Best haemato oncologist in India said the stem cell transplant” will quickly be regarded as an established treatment in India - and at the same time as that occurs our precedence may be making sure people who ought to gain can surely get it".

"In an autologous BMT process, the healthy stem cells from the affected individual are removed and preserved. Chemotherapy is then given to reset the body's immune system after which the stems are injected again into the individual’s body. After the surgical treatment, the patient is kept under isolation for some months to make sure he/she does now not agreement any infection," described Dr. Rahul Bhargava India.

Considering conventional steroid injections and immune procedures are expensive and don't promise a treatment, the best haemato oncologist in India thought of going for a BMT for Kumar, According to the patient, the attack is sudden and could have an impact on any part of your body, limiting your skills. "I suppose I am very fortunate to get to understand about Dr. Rahul Bhargava India and team, who cured me miraculously," Kumar said.

"Too immoderate postpone in the procedure can extensively have an effect on the medical consequences. as inside the case of Mr. Arjun, recuperation is around 90%, which means that he acquired the treatment inside healing time-body," in this example, we've were given proved that bone marrow transplant can be visible as a successful alternative treatment for multiple sclerosis patients, giving them a fresh shot at life," added best haemato oncologist in India, in a statement.

India Cancer Surgery

Mail Us:drrahulbhargava@indiacancersurgerysite.com

 
 
FAQs | Contact Us | Terms & Conditions | Privacy Policy
© 2024 Proserve Technology, Inc.